2022. Development and Optimization of Apixaban Loaded Solid Lipid Nanoparticles by Central Composite Design, in vitro and ex vivo Characterization. International Journal of Pharmaceutical Sciences and Drug Research. 14, 5 (Sep. 2022), 581–588. DOI:https://doi.org/10.25004/IJPSDR.2022.140511.